Centro Hospitalar Universitário Lisboa Norte, Faculdade de Medicina, Universidade de Lisboa, CAML, Lisbon, Portugal.
IQVIA, Barcelona, Spain.
Influenza Other Respir Viruses. 2023 Jan;17(1):e13066. doi: 10.1111/irv.13066. Epub 2022 Nov 14.
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infection (ALRI) in young children and is of considerable burden on healthcare systems. Our study aimed to evaluate ALRI hospitalizations related to RSV in children in Portugal.
We reviewed hospitalizations potentially related to RSV in children aged <5 years from 2015 to 2018, using anonymized administrative data covering all public hospital discharges in mainland Portugal. Three case definitions were considered: (a) RSV-specific, (b) (a) plus unspecified acute bronchiolitis (RSV-specific & Bronchiolitis), and (c) (b) plus unspecified ALRI (RSV-specific & ALRI).
A total of 9697 RSV-specific hospitalizations were identified from 2015 to 2018-increasing to 26 062 for RSV-specific & ALRI hospitalizations-of which 74.7% were during seasons 2015/2016-2017/2018 (November-March). Mean hospitalization rates per season were, for RSV-specific, RSV-specific & Bronchiolitis, and RSV-specific & ALRI, respectively, 5.6, 9.4, and 11.8 per 1000 children aged <5 years and 13.4, 22.5, and 25.9 in children aged <2 years. Most RSV-specific hospitalizations occurred in healthy children (94.9%) and in children aged <2 years (96.3%). Annual direct costs of €2.4 million were estimated for RSV-specific hospitalizations-rising to €5.1 million for RSV-specific & ALRI-mostly driven by healthy children (87.6%).
RSV is accountable for a substantial number of hospitalizations in children, especially during their first year of life. Hospitalizations are mainly driven by healthy children. The variability of the potential RSV burden across case definitions highlights the need for a universal RSV surveillance system to guide prevention strategies.
呼吸道合胞病毒(RSV)是导致婴幼儿急性下呼吸道感染(ALRI)的主要原因,对医疗保健系统造成了相当大的负担。我们的研究旨在评估葡萄牙儿童因 RSV 导致的 ALRI 住院情况。
我们使用涵盖葡萄牙大陆所有公立医院出院情况的匿名行政数据,回顾了 2015 年至 2018 年期间与儿童年龄<5 岁相关的潜在与 RSV 相关的住院治疗情况。考虑了三种病例定义:(a)RSV 特异性,(b)(a)加未特指的急性细支气管炎(RSV 特异性和细支气管炎),和(c)(b)加未特指的 ALRI(RSV 特异性和 ALRI)。
2015 年至 2018 年期间共发现 9697 例 RSV 特异性住院治疗病例,而 RSV 特异性和 ALRI 住院治疗病例增加到 26062 例,其中 74.7%发生在 2015/2016 年至 2017/2018 年季节(11 月至 3 月)。每个季节的 RSV 特异性、RSV 特异性和细支气管炎、RSV 特异性和 ALRI 的平均住院率分别为每 1000 名<5 岁儿童 5.6、9.4 和 11.8 例,每 1000 名<2 岁儿童 13.4、22.5 和 25.9 例。大多数 RSV 特异性住院治疗发生在健康儿童(94.9%)和<2 岁儿童(96.3%)中。估计 RSV 特异性住院治疗的直接年度费用为 240 万欧元,而 RSV 特异性和 ALRI 住院治疗的费用上升至 510 万欧元,主要由健康儿童(87.6%)引起。
RSV 导致儿童大量住院治疗,尤其是在他们的第一年生命中。住院治疗主要由健康儿童驱动。病例定义中 RSV 潜在负担的可变性突出表明需要建立一个通用的 RSV 监测系统来指导预防策略。